Nothing Special   »   [go: up one dir, main page]

ES2185658T3 - Vacuna para la otitis media. - Google Patents

Vacuna para la otitis media.

Info

Publication number
ES2185658T3
ES2185658T3 ES94922428T ES94922428T ES2185658T3 ES 2185658 T3 ES2185658 T3 ES 2185658T3 ES 94922428 T ES94922428 T ES 94922428T ES 94922428 T ES94922428 T ES 94922428T ES 2185658 T3 ES2185658 T3 ES 2185658T3
Authority
ES
Spain
Prior art keywords
fimbrine
dna
vaccine
otitis
codifies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94922428T
Other languages
English (en)
Inventor
Pappachan E Kolattukudy
Lauren O Bakaletz
Tatiana Sirakova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University Research Foundation
Original Assignee
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation
Application granted granted Critical
Publication of ES2185658T3 publication Critical patent/ES2185658T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE HA DESCUBIERTO QUE UNA VACUNA QUE COMPRENDE FIMBRINA, UNA PROTEINA FILAMENTOSA DERIVADA DE LOS APENDICES SUPERFICIALES BACTERIANOS DEL "HAEMOPHILUS INFLUENZAE" ES UTIL EN EL ESTUDIO, LA PREVENCION O LA REDUCCION DE LA SEVERIDAD DE LA OTITIS MEDIA. TAMBIEN SE HA DETERMINADO LA SECUENCIA DE GENES DEL DNA QUE CODIFICA LA FIMBRINA Y LA SECUENCIA DE AMINOACIDO DE LA FIMBRINA. TAMBIEN SE HAN DESARROLLADO VECTORES QUE CONTIENEN EL DNA QUE CODIFICA LA FIMBRINA, Y TRANSFORMANTES QUE HAN SIDO PREPARADOS Y QUE CONTIENEN TALES VECTORES Y QUE EXPRESAN DICHO DNA Y SUMINISTRAN UNA FUENTE DE FIMBRINA PURA.
ES94922428T 1993-05-18 1994-05-12 Vacuna para la otitis media. Expired - Lifetime ES2185658T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6544293A 1993-05-18 1993-05-18

Publications (1)

Publication Number Publication Date
ES2185658T3 true ES2185658T3 (es) 2003-05-01

Family

ID=22062752

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94922428T Expired - Lifetime ES2185658T3 (es) 1993-05-18 1994-05-12 Vacuna para la otitis media.

Country Status (9)

Country Link
US (3) US5766608A (es)
EP (2) EP1300156A3 (es)
JP (1) JP3429313B2 (es)
AT (1) ATE226831T1 (es)
DE (1) DE69431624T2 (es)
DK (1) DK0699076T3 (es)
ES (1) ES2185658T3 (es)
PT (1) PT699076E (es)
WO (1) WO1994026304A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3429313B2 (ja) 1993-05-18 2003-07-22 オハイオ・ステイト・リサーチ・ファウンデーション 中耳炎ワクチン
WO1994027435A1 (en) * 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
US5770213A (en) 1994-05-05 1998-06-23 American Cyanamid Company Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection
US5843464A (en) * 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
ES2296419T3 (es) * 1998-11-12 2008-04-16 Invitrogen Corporation Reactivos de transfeccion.
JP4846906B2 (ja) 1999-03-19 2011-12-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0117762D0 (en) * 2001-07-20 2001-09-12 Glaxosmithkline Biolog Sa Novel compounds
AU2003250204B8 (en) 2002-08-02 2008-07-10 Glaxosmithkline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens
AR041880A1 (es) 2002-11-01 2005-06-01 Glaxosmithkline Biolog Sa Composicion inmunogena
CA2539715C (en) 2003-10-02 2015-02-24 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
ATE488526T1 (de) * 2005-07-08 2010-12-15 Nationwide Childrens Hospital Chimärer impfstoff für haemophilus influenzae- induzierte infektion
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
LT2384765T (lt) 2005-12-22 2017-01-10 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae vakcina
SG175492A1 (en) 2006-01-17 2011-11-28 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein e; pe)
EA020817B1 (ru) 2007-06-26 2015-02-27 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
WO2009103068A1 (en) * 2008-02-15 2009-08-20 Life Technologies Corporation Methods and compositions for shearing of polymers by sonication
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
JP2013521327A (ja) 2010-03-10 2013-06-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
WO2012170356A1 (en) 2011-06-04 2012-12-13 Rochester General Hospital Research Institute Compositions and methods related to p6 of haemophilus influenzae
US9855326B2 (en) 2013-03-08 2018-01-02 Research Institute At Nationwide Children's Hospital Transcutaneous haemophilus influenzae vaccine formulations and methods
US10195280B2 (en) 2014-07-15 2019-02-05 Life Technologies Corporation Compositions and methods for efficient delivery of molecules to cells
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
GB2600652B (en) 2017-05-30 2022-11-02 Glaxosmithkline Biologicals Sa Novel compositions
EP3717001A1 (en) 2017-12-01 2020-10-07 GlaxoSmithKline Biologicals S.A. Saponin purification
BR112021000965A2 (pt) 2018-08-07 2021-04-27 Glaxosmithkline Biologicals S.A. processos e vacinas
EP3886901A1 (en) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Methods for manufacturing an adjuvant
WO2020245207A1 (en) 2019-06-05 2020-12-10 Glaxosmithkline Biologicals Sa Saponin purification
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
US5110908A (en) * 1986-12-31 1992-05-05 Praxis Biologics, Inc. Haemophilus influenzae peptides and proteins
JP3429313B2 (ja) 1993-05-18 2003-07-22 オハイオ・ステイト・リサーチ・ファウンデーション 中耳炎ワクチン

Also Published As

Publication number Publication date
PT699076E (pt) 2003-03-31
EP0699076A4 (en) 1999-09-08
EP0699076A1 (en) 1996-03-06
WO1994026304A1 (en) 1994-11-24
JPH09500104A (ja) 1997-01-07
DE69431624D1 (de) 2002-12-05
US6562349B1 (en) 2003-05-13
DK0699076T3 (da) 2003-03-03
EP0699076B1 (en) 2002-10-30
JP3429313B2 (ja) 2003-07-22
DE69431624T2 (de) 2003-07-10
EP1300156A3 (en) 2003-05-07
EP1300156A2 (en) 2003-04-09
US5766608A (en) 1998-06-16
US6030626A (en) 2000-02-29
ATE226831T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
ES2185658T3 (es) Vacuna para la otitis media.
ES2063965T3 (es) Vacunas para haemophilus influenzae no tipificable.
IE892272L (en) Novel fused heterocyclic compounds
AR056723A2 (es) Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid
GB9108652D0 (en) Immunoreactive compounds
ES2176128T1 (es) Genes de corynebacterium glutamicum que codifican proteinas implicadas en la homeostasis y la adaptacion.
BR9405720A (pt) Alfa-amilase mutante DNA vetores de expressão células hospedeiras composição detergente composição de liquefação de amido e processo para liquefazer uma suspensão de amido granular
ES2177476T1 (es) Genes de corynebacterium glutamicum que codifican proteinas implicadas en la sintesis de la membrana y el transporte a traves de la membrana.
NO965487D0 (no) Optiske hvitemidler
AU7528894A (en) Hydrazino-type n2s2 chelators
NO940736D0 (no) DNA sekvenser som koder for gelonin polypeptid
BR9811850A (pt) Expressão recombinante de peptìdeo c de insulina
NO972313D0 (no) Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav
DK0789764T3 (da) Ny familie af proteaseinhibitorer og andre biologisk aktive substanser
ES2066510T3 (es) Nuevos polipeptidos con afinidad para lipopolisacaridos y sus usos.
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
DK0946590T3 (da) Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid
ES2170144T3 (es) Variantes que no se empalman de gp350/220.
NO178870C (no) Fremgangsmåte for fremstilling av modifisert Eglin B eller C samt DNA, ekspresjonsvektor og vertsmikroorganisme
HU9500619D0 (en) Cloning and expression of b-app-c100 receptor
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
AU1300283A (en) Chromophoric peptides
ZA916106B (en) Cloning and expression of a rhoptry-associated protein of p.falciparum
HUT63196A (en) Process for producing and applying new cloning and expression vectors